PLUSS ties up with The Rodnight Partnership to enhance availability of its neonatal cooling device 'MiraCradle®' in developing countries

MiraCradle® has also been included in the WHO compendium of 'Affordable Innovative Health Technologies' and has been granted a patent in the United States, Europe, Brazil, South Africa, Malaysia and India. Its development team members have received MIT's 'Innovators Under 35' award.  MiraCradle® has also been included in the WHO compendium of 'Affordable Innovative Health Technologies' and has been granted a patent inthe United States,Europe,Brazil,South Africa,MalaysiaandIndia...

MiraCradle® has also been included in the WHO compendium of 'Affordable Innovative Health Technologies' and has been granted a patent in the United States, Europe, Brazil, South Africa, Malaysia and India. Its development team members have received MIT's 'Innovators Under 35' award. 

"MiraCradle® offers a safe, more controlled and low-cost cooling compared to servo-controlled cooling equipment. It would be particularly significant for facilities that are resource constrained, and where travel distances to tertiary care centres might be substantial. We are happy to partner with The Rodnight Partnership to enhance availability of this device in the Global South," said Udit Mangal, Vice President & Business Head-Lifesciences, Pluss Advanced Technologies. "We have also received interest from a number of manufacturers for licensing this technology and are actively evaluating it to further the worldwide availability of MiraCradle®," he added.

The Rodnight Partnership assists medical manufacturing companies in their international endeavours. This initiative aligns with the G20 declaration, of facilitating equitable access to safe, effective and affordable therapeutics and diagnostics, especially in low-and middle-income countries.

About PLUSS

Pluss Advanced Technologies started with R&D and manufacturing of specialized polymers, in 1994. In 2007 PLUSS commenced development of Phase Change Materials, in 2012, it raised funds from Tata Capital Innovations Fund, expanded R&D and commercialized innovative temperature control solutions using proprietary materials, which addressed unmet needs of temperature control across refrigeration, cold-chain logistics and healthcare. PLUSS now has demand for its technology from various parts of the world and has opened a subsidiary in the Netherlands. Since 2021, PLUSS is a subsidiary of Carborundum Universal Limited (CUMI), a Murugappa Group company. Please also visit www.pluss.co.in, www.miracradle.com

 

View original content:https://www.prnewswire.co.uk/news-releases/pluss-ties-up-with-the-rodnight-partnership-to-enhance-availability-of-its-neonatal-cooling-device-miracradle-in-developing-countries-301930063.html